Cancer Immunity & Immunotherapy Course

Tuesday, June 20, 2023

7:30 AM – 5:45 PM

Location: Gloucester Room, 3rd Floor

Co-Author(s)

Asha B. Pillai, MD

Chair, Hematology and Transplantation, Global Development Scientific Council
Regeneron Therapeutics Inc
Tarrytown, New York, United States
Jennifer L. Guerriero, Ph.D.

Assistant Professor
Brigham and Women's Hospital
Needham, Massachusetts, United States

Speaker(s)

Abul Abbas, MD

University of California, San Francisco
Matthew H. Spitzer, Ph.D.

University of California, San Francisco
San Francisco, California, United States
Mary Philip, PhD
Alexandra-Chloe Villani, Ph.D.

Assistant Professor of Medicine
Massachusetts General Hospital, Broad Institute
Charlestown, Massachusetts, United States
Joshua Brody, MD
Catherine J. Wu, MD

Professor of Medicine Chief, Division of Stem Cell Transplantation and Cellular Therapies Dana-Farber Cancer Institute and Harvard Medical School
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Rizwan Romee, MD
Israel Lowy, MD
Shashank Patel, Ph.D.
Daniel Kirouac, Ph.D.

7:30-8:00 am Continental Breakfast
8:00-8:45 am Principles of Tumor Immunity – Abul Abbas, MD, UCSF
8:45-9:30 am The Tumor Microenvironment – Matthew Spitzer, PhD, UCSF (pending)
9:30-10:15 am B Cells – Tullia Bruno, PhD, University of Pittsburgh
10:15-10:30 am Coffee Break
10:30-11:15 am T Cell Exhaustion – Mary Philip, MD, PhD, Vanderbilt University Medical Center
11:15 am-12:00 pm Immune-Mediated Toxicities – Alexandra-Chloe Villani, PhD, Massachusetts General Hospital
12:00-12:45 pm Lunch
12:45-1:30 pm Shiny New CARs – Joshua Brody, MD, Mount Sinai
1:30-2:15 pm Tumor Vaccines – Catherine Wu, MD, Dana Farber Cancer Institute
2:15-2:30 pm Coffee Break
2:30-3:15 pm Innovations with NK Cells – Rizwan Romee, MD, Dana Farber Cancer Institute
3:15-4:00 pm Combinatorial Therapeutics in Solid Tumors – Israel Lowy, MD, PhD, Regeneron
4:00-4:15 pm Break (No coffee)
4:15-5:00 pm Challenges 1: Real-Time Analyses of Tumor Immunotherapy Evasion – Shashank Patel, PhD, Immunai Corp
5:00-5:45 pm Challenges 2: Quantitative Analysis of CAR-T Cell Pharmacology and Response – Daniel Kirouac, PhD, Notch Therapeutics